IBDEI3IV ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,2183,0)
 ;;=COUNSELING^3^197
 ;;^UTILITY(U,$J,358.4,2184,0)
 ;;=PREVENTIVE HEALTH ENCOUNTER^1^197
 ;;^UTILITY(U,$J,358.4,2185,0)
 ;;=HISTORY OF ILLNESS^4^197
 ;;^UTILITY(U,$J,358.4,2186,0)
 ;;=LONG TERM DRUG USE^5^197
 ;;^UTILITY(U,$J,358.4,2187,0)
 ;;=OTHER^10^197
 ;;^UTILITY(U,$J,358.4,2188,0)
 ;;=SCREENING^6^197
 ;;^UTILITY(U,$J,358.4,2189,0)
 ;;=TRANSPLANT^7^197
 ;;^UTILITY(U,$J,358.4,2190,0)
 ;;=VACCINATIONS^8^197
 ;;^UTILITY(U,$J,358.4,2191,0)
 ;;=WOMEN'S HEALTH^9^197
 ;;^UTILITY(U,$J,358.4,2192,0)
 ;;=NEW PATIENT^2^198
 ;;^UTILITY(U,$J,358.4,2193,0)
 ;;=ESTABLISHED PATIENT^1^198
 ;;^UTILITY(U,$J,358.4,2194,0)
 ;;=CONSULTATIONS^3^198
 ;;^UTILITY(U,$J,358.4,2195,0)
 ;;=IMMUNIZATION^6^199
 ;;^UTILITY(U,$J,358.4,2196,0)
 ;;=INJECTION^7^199
 ;;^UTILITY(U,$J,358.4,2197,0)
 ;;=SKIN TEST^16^199
 ;;^UTILITY(U,$J,358.4,2198,0)
 ;;=NURSING PROCEDURES^9^199
 ;;^UTILITY(U,$J,358.4,2199,0)
 ;;=MINOR PROCEDURES^8^199
 ;;^UTILITY(U,$J,358.4,2200,0)
 ;;=SPLINTS^17^199
 ;;^UTILITY(U,$J,358.4,2201,0)
 ;;=EDUCATION/TRAINING^3^199
 ;;^UTILITY(U,$J,358.4,2202,0)
 ;;=ALLERGY SHOTS^1^199
 ;;^UTILITY(U,$J,358.4,2203,0)
 ;;=EKG^4^199
 ;;^UTILITY(U,$J,358.4,2204,0)
 ;;=BEHAVIORAL CHANGE INTERVENTION^2^199
 ;;^UTILITY(U,$J,358.4,2205,0)
 ;;=OTH PREVENTIVE MEDICINE SVCS^10^199
 ;;^UTILITY(U,$J,358.4,2206,0)
 ;;=GYN PROCEDURES^5^199
 ;;^UTILITY(U,$J,358.4,2207,0)
 ;;=PREVENTIVE MED-EST PT^12^199
 ;;^UTILITY(U,$J,358.4,2208,0)
 ;;=PREVENTIVE MED-NEW PT^13^199
 ;;^UTILITY(U,$J,358.4,2209,0)
 ;;=RISK FACTOR REDUCTION^15^199
 ;;^UTILITY(U,$J,358.4,2210,0)
 ;;=PREVENTIVE GROUP COUNSELING^11^199
 ;;^UTILITY(U,$J,358.4,2211,0)
 ;;=PROLONGED SERVICE^14^199
 ;;^UTILITY(U,$J,358.4,2212,0)
 ;;=PC COMMON DIAGNOSES^1^200
 ;;^UTILITY(U,$J,358.4,2213,0)
 ;;=ADMINISTRATIVE TOPICS^2^200
 ;;^UTILITY(U,$J,358.4,2214,0)
 ;;=ANGINA^3^200
 ;;^UTILITY(U,$J,358.4,2215,0)
 ;;=ATHEROSCLEROSIS^4^200
 ;;^UTILITY(U,$J,358.4,2216,0)
 ;;=CARDIOVASCULAR^5^200
 ;;^UTILITY(U,$J,358.4,2217,0)
 ;;=DERMATOLOGY^9^200
 ;;^UTILITY(U,$J,358.4,2218,0)
 ;;=EAR DISORDERS^10^200
 ;;^UTILITY(U,$J,358.4,2219,0)
 ;;=EENT^11^200
 ;;^UTILITY(U,$J,358.4,2220,0)
 ;;=ENDOCRINE/METABOLIC^12^200
 ;;^UTILITY(U,$J,358.4,2221,0)
 ;;=EYE DISORDERS^13^200
 ;;^UTILITY(U,$J,358.4,2222,0)
 ;;=EYE INJURY^14^200
 ;;^UTILITY(U,$J,358.4,2223,0)
 ;;=GASTROENTEROLOGY^15^200
 ;;^UTILITY(U,$J,358.4,2224,0)
 ;;=GU/RENAL^16^200
 ;;^UTILITY(U,$J,358.4,2225,0)
 ;;=HEADACHE^17^200
 ;;^UTILITY(U,$J,358.4,2226,0)
 ;;=HEART FAILURE^18^200
 ;;^UTILITY(U,$J,358.4,2227,0)
 ;;=HEART VALVE DISEASE^19^200
 ;;^UTILITY(U,$J,358.4,2228,0)
 ;;=HEMATOLOGY/ONCOLOGY^20^200
 ;;^UTILITY(U,$J,358.4,2229,0)
 ;;=HISTORY OF ILLNESS^21^200
 ;;^UTILITY(U,$J,358.4,2230,0)
 ;;=INFECTIOUS DISEASE^22^200
 ;;^UTILITY(U,$J,358.4,2231,0)
 ;;=LIVER DISEASE^23^200
 ;;^UTILITY(U,$J,358.4,2232,0)
 ;;=MENTAL HEALTH^25^200
 ;;^UTILITY(U,$J,358.4,2233,0)
 ;;=MOVEMENT DISORDERS^26^200
 ;;^UTILITY(U,$J,358.4,2234,0)
 ;;=MUSCULOSKELETAL^27^200
 ;;^UTILITY(U,$J,358.4,2235,0)
 ;;=NEUROLOGY^28^200
 ;;^UTILITY(U,$J,358.4,2236,0)
 ;;=PAIN^29^200
 ;;^UTILITY(U,$J,358.4,2237,0)
 ;;=PREVENTIVE HEALTH^30^200
 ;;^UTILITY(U,$J,358.4,2238,0)
 ;;=PULMONARY^31^200
 ;;^UTILITY(U,$J,358.4,2239,0)
 ;;=SEXUAL TRAUMA^32^200
 ;;^UTILITY(U,$J,358.4,2240,0)
 ;;=SIGNS,SYMPTOMS,CONDITIONS^33^200
 ;;^UTILITY(U,$J,358.4,2241,0)
 ;;=SPRAIN/STRAIN-INITIAL ENCOUNTER^34^200
 ;;^UTILITY(U,$J,358.4,2242,0)
 ;;=SUBSTANCE DISORDERS^35^200
 ;;^UTILITY(U,$J,358.4,2243,0)
 ;;=VARICOSE VEINS^36^200
 ;;^UTILITY(U,$J,358.4,2244,0)
 ;;=WOMEN'S HEALTH^37^200
